Learn about CVE-2018-17538, a disputed vulnerability in Axon Evidence Sync 3.15.89 related to process injection. Find out the impact, technical details, and mitigation steps.
Axon (formerly TASER International) Evidence Sync 3.15.89 has a vulnerability related to process injection, although the vendor disputes this claim.
Understanding CVE-2018-17538
This CVE entry relates to a disputed vulnerability in the Axon Evidence Sync software.
What is CVE-2018-17538?
The software Axon (previously known as TASER International) Evidence Sync 3.15.89 is reported to have a vulnerability associated with process injection. However, the vendor denies the existence of any evidence supporting such a vulnerability in the software.
The Impact of CVE-2018-17538
As the vulnerability is disputed, the actual impact may vary. Users should be cautious and follow any updates or recommendations from the vendor.
Technical Details of CVE-2018-17538
This section provides technical insights into the CVE.
Vulnerability Description
The vulnerability in Axon Evidence Sync 3.15.89 is related to process injection, a technique used by attackers to run arbitrary code within the address space of another process.
Affected Systems and Versions
Exploitation Mechanism
The exploitation of this vulnerability could allow threat actors to inject malicious code into the software, potentially leading to unauthorized access or other security breaches.
Mitigation and Prevention
Protective measures and actions to address the CVE.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates
Stay informed about any official patches or fixes released by the vendor to address the disputed vulnerability in Axon Evidence Sync 3.15.89.